AGER and lung cancer: Oczypok et al. claimed that even though RAGE expression is likely to increase in the lung tumor cells, the bronchogenic tumors appear to have less RAGE than healthy lungs with large numbers of AT1 cells, because the predominant cell-type in lung cancers is the bronchial epithelial cell, which does not typically express RAGE17.